Cadre Holdings, Inc. (CDRE): Cost of Revenue

Annual figures by period end, from SEC filings.

$350.68M

Year ended 2025-12-31

$399.10M

Trailing 12 months to 2026-06-30

+7.5%

3-year compound annual growth

+6.9%

5-year compound annual growth

2020-12-31 Cost of Revenue (USD) 2025-12-31

Period ended	Cost of Revenue	Change YoY	Source filing
2025-12-31	$350.68M	+5.0%	2026-03-10, From 2025-01-01
2024-12-31	$334.08M	+18.5%	2026-03-10, From 2024-01-01
2023-12-31	$281.81M	-0.1%	2026-03-10, From 2023-01-01
2022-12-31	$282.16M	+10.0%	2025-03-11, From 2022-01-01
2021-12-31	$256.60M	+1.9%	2024-03-12, From 2021-01-01
2020-12-31	$251.70M	n/a	2022-03-11, From 2020-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Orthopedic, Prosthetic & Surgical Appliances & Supplies), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Cost of Revenue	Change YoY
Cadre Holdings, Inc. (CDRE)	2025-12-31	$350.68M	+5.0%
Inogen Inc (INGN)	2025-12-31	$194.40M	+7.4%
Establishment Labs Holdings Inc. (ESTA)	2025-12-31	$64.77M	+14.6%
MSA Safety Inc (MSA)	2025-12-31	$1.00B	+5.9%
Lakeland Industries Inc (LAKE)	2026-01-31	$129.32M	+31.2%
Enovis Corp (ENOV)	2025-12-31	$902.79M	-2.6%
Sanara MedTech Inc. (SMTI)	2025-12-31	$7.52M	-7.6%
Align Technology Inc (ALGN)	2025-12-31	$1.32B	+10.3%
Steris PLC (STE)	2026-03-31	$3.31B	+8.3%

Compare CDRE, INGN, ESTA, MSA side by side · Screen every company in Orthopedic, Prosthetic & Surgical Appliances & Supplies ↗